title: [Anti-angiogenic therapy associated with laser photocoagulation in the treatment of subretinal neovascular membrane: case report].
abstract: The aim of this report is to describe a case of age-related macular degeneration with juxtafoveal subretinal neovascular membrane, initially treated with intravitreal bevacizumab (Avastin(®)) and afterwards with focal photocoagulation laser therapy. The efficacy of the initial and complementary treatment was evaluated through the visual acuity measurement and complementary exams (fluorescein angiography and optical coherence tomography). After three bevacizumab intravitreal injections , it has occurred the eccentric reduction of the neovascular subretinal membrane, changing its classification to extrafoveal, what allowed the subsequent treatment with focal photocoagulation laser therapy.
authors.affiliation: Clínica Suporte Diagnóstico em Oftalmologia, Rio de Janeiro, Brazil.
authors.forename: José Alexandre Bastos
authors.initials: JA
authors.lastname: Pereira
authors.forename: Isabela Soutello
authors.initials: IS
authors.lastname: Camarota
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D003131:Combined Modality Therapy / Q000379:methods; D005451:Fluorescein Angiography; D006801:Humans; D008028:Light Coagulation; D008297:Male; D015861:Retinal Neovascularization / Q000175:diagnosis / Q000628:therapy*; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab